World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
75
Citations
27051
World Ranking
19018
National Ranking
216

Overview

Kimmo Porkka is affiliated with the University of Helsinki in Finland and conducts research primarily within the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their work focuses extensively on hematological malignancies and molecular biology, with significant contributions to Oncology and Immunology as well.

The scientist has published extensively on topics related to acute and chronic myeloid leukemias as well as multiple myeloma research and treatments. Their main research themes include:

  • Acute Myeloid Leukemia Research
  • Chronic Myeloid Leukemia Treatments
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Multiple Myeloma Research and Treatments
  • Histone Deacetylase Inhibitors Research
  • Cancer Genomics and Diagnostics
  • Acute Lymphoblastic Leukemia research

Porkka's publication record includes important papers such as:

  • "Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia," 2020, New England Journal of Medicine
  • "International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data," 2022, Blood
  • "Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission," 2020, New England Journal of Medicine
  • "Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid Leukemia," 2021, Cancer Discovery
  • "Long-term follow-up of VIALE-A: Venetoclax and azacitidine in chemotherapy-ineligible untreated acute myeloid leukemia," 2024, American Journal of Hematology

The frequent venues where Porkka's work appears include:

  • Blood
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Clinical Lymphoma Myeloma & Leukemia
  • Leukemia
  • HemaSphere

Collaboration is a significant aspect of their research approach, with frequent co-authors being:

  • Mika Kontro
  • Caroline A. Heckman
  • Andrew H. Wei
  • Heikki Kuusanmäki
  • Krister Wennerberg

Kimmo Porkka's research contributes to advancing the understanding and treatment of hematological cancers by integrating clinical, morphologic, genomic, and functional precision medicine approaches within their studies.

Best Publications

  • Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia

    Courtney D DiNardo;Brian A Jonas;Vinod Pullarkat;Michael J Thirman

  • Somatic STAT3 Mutations in Large Granular Lymphocytic Leukemia

    Hanna L.M. Koskela;Samuli Eldfors;Pekka Ellonen;Arjan J. van Adrichem

  • The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts

    Camille Abboud;Ellin Berman;Adam Cohen

  • Effects of Persistent Physical Activity and Inactivity on Coronary Risk Factors in Children and Young Adults The Cardiovascular Risk in Young Finns Study

    O. T. Raitakari;K. V. K. Porkka;S. Taimela;R. Telama

  • A tumor-homing peptide with a targeting specificity related to lymphatic vessels

    Pirjo Laakkonen;Kimmo Porkka;Jason A Hoffman;Erkki Ruoslahti

  • Predicting complete cytogenetic response and subsequent progression-free survival in 2060 patients with CML on imatinib treatment: the EUTOS score

    Joerg Hasford;Michele Baccarani;Verena Hoffmann;Joelle Guilhot

  • Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels

    Sven Christian;Jan Pilch;Maria E. Akerman;Maria E. Akerman;Kimmo Porkka;Kimmo Porkka

  • Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome-positive leukemia.

    Kimmo Porkka;Perttu Koskenvesa;Tuija Lundán;Johanna Rimpiläinen

  • Bcr-Abl kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: recommendations from an expert panel on behalf of European LeukemiaNet

    Simona Soverini;Andreas Hochhaus;Franck E. Nicolini;Franz Gruber

  • European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia

    J.L. Steegmann;M. Baccarani;M. Breccia;L.F. Casado

  • STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia

    Andres Jerez;Michael J. Clemente;Hideki Makishima;Hanna Koskela

  • Individualized Systems Medicine Strategy to Tailor Treatments for Patients with Chemorefractory Acute Myeloid Leukemia

    Tea Pemovska;Mika Kontro;Bhagwan Yadav;Henrik Edgren

  • A fragment of the HMGN2 protein homes to the nuclei of tumor cells and tumor endothelial cells in vivo

    Kimmo Porkka;Pirjo Laakkonen;Jason A. Hoffman;Michele Bernasconi

  • Quantitative scoring of differential drug sensitivity for individually optimized anticancer therapies

    Bhagwan Yadav;Tea Pemovska;Agnieszka Szwajda;Evgeny Kulesskiy

  • Clonal expansion of T/NK-cells during tyrosine kinase inhibitor dasatinib therapy

    S. Mustjoki;M. Ekblom;T. P. Arstila;I. Dybedal

  • Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia

    Hanna L. M. Rajala;Samuli Eldfors;Heikki Kuusanmäki;Arjan J. van Adrichem

  • Linkage of familial combined hyperlipidaemia to chromosome 1q21-q23

    Päivi Pajukanta;Ilpo Nuotio;Joseph D. Terwilliger;Kimmo V.K. Porkka

  • Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission.

    Andrew H. Wei;Hartmut Döhner;Christopher Pocock;Pau Montesinos

  • Progressive vascular changes in a transgenic mouse model of squamous cell carcinoma

    Jason A. Hoffman;Enrico Giraudo;Mallika Singh;Lianglin Zhang

  • Clonal Expansion of T/NK-Cells during Tyrosine Kinase Inhibitor Dasatinib Therapy

    Satu Mustjoki;Marja Ekblom;T. Petteri Arstila;Ingunn Dybedal

Frequent Co-Authors

Satu Mustjoki
Satu Mustjoki University of Helsinki
Olli Kallioniemi
Olli Kallioniemi Karolinska Institute
Bjørn Tore Gjertsen
Bjørn Tore Gjertsen Haukeland University Hospital
Tero Aittokallio
Tero Aittokallio University of Helsinki
Andreas Hochhaus
Andreas Hochhaus Friedrich Schiller University Jena
Jorma Viikari
Jorma Viikari Turku University Hospital
Andrew Wei
Andrew Wei Walter and Eliza Hall Institute of Medical Research
Michele Baccarani
Michele Baccarani University of Bologna
Olli T. Raitakari
Olli T. Raitakari Turku University Hospital
Janna Saarela
Janna Saarela University of Helsinki

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a career in medicine doesn’t always mean becoming a physician. There are a variety of online health administration programs that offer skills in leadership, healthcare policy, and organization management. These programs open doors to roles in hospital administration or healthcare operations.

For registered nurses looking to expand their qualifications, rn to np bridge programs offer a streamlined pathway to becoming nurse practitioners. This progression can lead to advanced clinical roles and greater autonomy within healthcare teams.

Those with an interest in wellness and dietetics might consider online degrees in nutrition. These flexible degrees focus on food science, nutrition therapy, and behavior change, preparing graduates for careers in clinical settings or community health.

Ambitious students interested in healthcare management can also explore the cahme accredited online mha programs list. Earning a CAHME-accredited Master of Health Administration online is ideal for those wanting trusted credentials and the ability to move into executive leadership roles.

Best Scientists Citing Kimmo Porkka

Trending Scientists